Clinical Trial Update: HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) [Phase 3]

View source ↗

Summary

This Phase 3 trial (PREVENT) is comparing HIPEC plus FLOT to FLOT alone in gastric cancer and gastroesophageal junction adenocarcinoma. The study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Krankenhaus Nordwest | Conditions: Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 3 | Status: RECRUITING